Centre for Innovative Biomedicine and Biotechnology
CIBB is a Research Unit of excellence at the University of Coimbra, and an international reference in the domains of Biomedicine and Biotechnology.
Data from 2018-2023
>3400
Publications
Researchers from
Faculties of Medicine, Pharmacy, Sciences and Economics
Coimbra Clinical Unit (ULS Coimbra)
Key collaborators from biotech and pharma industry
More than 700 members
309 Integrated PhD-holders
232 PhD students
171 Other collaborators
Research-oriented Advanced Training
Participation in 8 PhD Programs
Participation in 7 MSc Programs
European Training Networks (H2020 MSCA‑ETN)
Highly Internationalized Research
50% of publications as
International Collaborations
Projects
International Projects funded by the European Union, International Foundations and the Private Sector
Clinicians at CIBB
>50 clinicians
In several areas
Technology Transfer
31 active IP families
10 Granted IP
10 active Spin-offs
> 20 academia-industry contracts
Prizes
Pfizer Award in basic research
L'Oréal Portugal Medal of Honor for Women in Science
Euretina Award
Several CIBB Researchers have leadership roles in major scientific societies in Portugal (e.g. Neuroscience, Biochemistry, Stem Cells & Cell Therapies and Pharmacology) and elsewhere (e.g. Human Genetics, Microbiology, Clinical Investigation and Controlled Release Society).
Science Communication
> 4500 news | AdvertisingValue >16 M € | Audiences >200 M
> 26 K social networks followers
Public Engagement Activities | > 32 K people reached | > 400 researchers involved | > 25 non-academic collaborations
Data from 2018 - 2023
We use cookies to improve your visit to our website.
